Projects

Reducing AIDS stigma among healthcare professionals in South India (in medical students)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2015 - Ongoing

Project Lead

Dr. Tony Raj, Dr. K Srinivasan, Dr. Maria Ekstrand

Authors

Dr. Tony Raj, Dr. K Srinivasan, Dr. Maria Ekstrand

Project Status

completed

Project Type

Center for Emerging & Neglected Diseases (CEND) UC Berkeley, USA